Canada · Delayed Price · Currency is CAD Gemina Laboratories Statistics
Total Valuation
CSE:GLAB has a market cap or net worth of CAD 30.25 million. The enterprise value is 30.47 million.
| Market Cap | 30.25M |
| Enterprise Value | 30.47M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:GLAB has 76.57 million shares outstanding. The number of shares has increased by 2.03% in one year.
| Current Share Class | 76.57M |
| Shares Outstanding | 76.57M |
| Shares Change (YoY) | +2.03% |
| Shares Change (QoQ) | +2.15% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | n/a |
| Float | 43.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,780.43 |
| PB Ratio | -6.88 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.60 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -181.71% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 86.81% |
| Revenue Per Employee | 1,813 |
| Profits Per Employee | -668,209 |
| Employee Count | 6 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.70% in the last 52 weeks. The beta is 0.22, so CSE:GLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +19.70% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 25.34 |
| Average Volume (20 Days) | 1,293 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:GLAB had revenue of CAD 10,878 and -4.01 million in losses. Loss per share was -0.05.
| Revenue | 10,878 |
| Gross Profit | 10,878 |
| Operating Income | -3.81M |
| Pretax Income | -4.01M |
| Net Income | -4.01M |
| EBITDA | -3.80M |
| EBIT | -3.81M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 14,974 in cash and 243,649 in debt, giving a net cash position of -228,675 or -0.00 per share.
| Cash & Cash Equivalents | 14,974 |
| Total Debt | 243,649 |
| Net Cash | -228,675 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -4.39M |
| Book Value Per Share | -0.06 |
| Working Capital | -5.46M |
Cash Flow
| Operating Cash Flow | -465,260 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -35,070.05% |
| Pretax Margin | -36,856.52% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:GLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.03% |
| Shareholder Yield | n/a |
| Earnings Yield | -13.26% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSE:GLAB has an Altman Z-Score of -36.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -36.36 |
| Piotroski F-Score | 1 |